575 MADISON AVENUE, NEW YORK, NY
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Financial Results, Press Release
Director Retirement - Zachary Prensky to Step Down from Board
Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
Announces $100.0 Million Private Placement
LB Pharmaceuticals Inc Enters Lease Amendment for Expansion Premises
Appoints Kaya Pai Panandiker as Chief Commercial Officer
Q1
Q3
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
S-1MEF